Main Menu
09
Dec
2018

Immunotherapy appeal raises over £80,000 for our research

Tina Manning

Thanks to the generosity of our donors, we have raised over £80,000 to help fund our cutting-edge work in immunotherapy through a fundraising appeal.

Immunotherapy uses the body’s own immune system – our in-built arsenal of cells and molecules that fight infection and disease – as a weapon against cancer. Some immunotherapies have shown spectacular responses, effectively curing patients with advanced cancer, including in melanoma and head and neck cancer.

Scientists at The Institute of Cancer Research are pioneers in immunotherapy research, having led some of the trials that have brought these treatments into the NHS and developed innovative new approaches in immunotherapy, including viral immunotherapy.

With the additional funds raised from the appeal, we will be able to build on these advances to make sure immunotherapy will benefit more patients in the future.

We are incredibly grateful to all our donors who supported the appeal, which you can still donate to.

Research at the ICR is underpinned by generous contributions from our supporters. Find out more about how you can contribute to our mission to make the discoveries to defeat cancer.

Read more

Support our research

Earlier this year we also raised a further £38,000 for other areas of our work, including research into prostate cancer and a rare type of sarcoma called rhabdomyosarcoma.

Overall, more than 3,000 supporters gave an incredible £120,000 – a record-breaking amount.

You can also support our new Christmas Appeal, which will help us in our efforts to defeat childhood leukaemia.

Find out more

This story first appeared in our supporter newsletter, Search.

To make sure you’re the first to hear the big stories from our labs, sign up to receive Search by email

Tags

Mel Greaves fundraising immunotherapy childhood leukaemia patient advocate
comments powered by Disqus